Tsourdi E - Search Results

1

Osteoporosis Treatment with Anti-Sclerostin Antibodies-Mechanisms of Action and Clinical Application.

Rauner M, Taipaleenmäki H, Tsourdi E, Winter EM. Rauner M, et al. Among authors: tsourdi e. J Clin Med. 2021 Feb 16;10(4):787. doi: 10.3390/jcm10040787. J Clin Med. 2021. PMID: 33669283 Free PMC article. Review.

2

Denosumab for bone diseases: translating bone biology into targeted therapy.

Tsourdi E, Rachner TD, Rauner M, Hamann C, Hofbauer LC. Tsourdi E, et al. Eur J Endocrinol. 2011 Dec;165(6):833-40. doi: 10.1530/EJE-11-0454. Epub 2011 Aug 18. Eur J Endocrinol. 2011. PMID: 21852390 Review.

3

Skeletal and extraskeletal actions of denosumab.

Sinningen K, Tsourdi E, Rauner M, Rachner TD, Hamann C, Hofbauer LC. Sinningen K, et al. Among authors: tsourdi e. Endocrine. 2012 Aug;42(1):52-62. doi: 10.1007/s12020-012-9696-x. Epub 2012 May 13. Endocrine. 2012. PMID: 22581255 Review.

4

Selective glucocorticoid receptor modulation maintains bone mineral density in mice.

Thiele S, Ziegler N, Tsourdi E, De Bosscher K, Tuckermann JP, Hofbauer LC, Rauner M. Thiele S, et al. Among authors: tsourdi e. J Bone Miner Res. 2012 Nov;27(11):2242-50. doi: 10.1002/jbmr.1688. J Bone Miner Res. 2012. PMID: 22714558 Free article.

5

Graves' disease after treatment with alemtuzumab for multiple sclerosis.

Tsourdi E, Gruber M, Rauner M, Blankenburg J, Ziemssen T, Hofbauer LC. Tsourdi E, et al. Hormones (Athens). 2015 Jan-Mar;14(1):148-53. doi: 10.14310/horm.2002.1501. Hormones (Athens). 2015. PMID: 25402383 Free article.

6

Hyperthyroidism and Hypothyroidism in Male Mice and Their Effects on Bone Mass, Bone Turnover, and the Wnt Inhibitors Sclerostin and Dickkopf-1.

Tsourdi E, Rijntjes E, Köhrle J, Hofbauer LC, Rauner M. Tsourdi E, et al. Endocrinology. 2015 Oct;156(10):3517-27. doi: 10.1210/en.2015-1073. Epub 2015 Jul 28. Endocrinology. 2015. PMID: 26218891

7

Thyrotropin serum levels are differentially associated with biochemical markers of bone turnover and stiffness in women and men: results from the SHIP cohorts.

Tsourdi E, Wallaschofski H, Rauner M, Nauck M, Pietzner M, Rettig R, Ittermann T, Völzke H, Völker U, Hofbauer LC, Hannemann A. Tsourdi E, et al. Osteoporos Int. 2016 Feb;27(2):719-27. doi: 10.1007/s00198-015-3276-x. Epub 2015 Aug 12. Osteoporos Int. 2016. PMID: 26264603

8

Sclerostin Blockade and Zoledronic Acid Improve Bone Mass and Strength in Male Mice With Exogenous Hyperthyroidism.

Tsourdi E, Lademann F, Ominsky MS, Rijntjes E, Köhrle J, Misof BM, Roschger P, Klaushofer K, Hofbauer LC, Rauner M. Tsourdi E, et al. Endocrinology. 2017 Nov 1;158(11):3765-3777. doi: 10.1210/en.2017-00247. Endocrinology. 2017. PMID: 28973221

9

Thy-1 (CD90) promotes bone formation and protects against obesity.

Picke AK, Campbell GM, Blüher M, Krügel U, Schmidt FN, Tsourdi E, Winzer M, Rauner M, Vukicevic V, Busse B, Salbach-Hirsch J, Tuckermann JP, Simon JC, Anderegg U, Hofbauer LC, Saalbach A. Picke AK, et al. Among authors: tsourdi e. Sci Transl Med. 2018 Aug 8;10(453):eaao6806. doi: 10.1126/scitranslmed.aao6806. Sci Transl Med. 2018. PMID: 30089635

10

Physiological and pathological osteocytic osteolysis.

Tsourdi E, Jähn K, Rauner M, Busse B, Bonewald LF. Tsourdi E, et al. J Musculoskelet Neuronal Interact. 2018 Sep 1;18(3):292-303. J Musculoskelet Neuronal Interact. 2018. PMID: 30179206 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

84 results

Search Page